pH-Sensitive Polymersomes for Intracellular Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing drug delivery systems face challenges in efficiently delivering pharmacological doses to targeted intracellular sites while avoiding lysosomal degradation and systemic toxicity, particularly for diseases like cancer, diabetes, and autoimmune diseases.

Innovation Solution

Development of pH-sensitive polymersomes composed of a protein repellent polymer and a biodegradable succinate polymer with a pendant group having a pKa of 4 to 7, which self-assemble at physiological pH and disassemble at mild acidic intracellular pH, enabling targeted intracellular drug delivery and avoiding lysosomal degradation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional drug delivery systems are used, then drugs can be delivered to targeted sites, but they suffer from lysosomal degradation and systemic toxicity

Engineering Contradiction:
Improvedrug delivery efficacyVSAvoidlysosomal degradation and systemic toxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The polymer's properties change in response to pH parameter changes. The polymer is hydrophobic at neutral pH for stable encapsulation but becomes hydrophilic at acidic pH (endosomal/lysosomal conditions) to trigger disassembly and drug release, avoiding lysosomal degradation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a composite amphiphilic block copolymer structure combining hydrophobic and hydrophilic blocks with specific functional groups (carboxylic acid, imidazole, amine) that provide both structural integrity and pH-responsive behavior for targeted delivery

Inventive Principle:
Principle #40Composite materials

2Reliability

If pH-sensitive polymers are used to avoid lysosomal degradation, then intracellular release is improved, but polymer complexity increases

Engineering Contradiction:
Improveintracellular drug releaseVSAvoidpolymer structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The polymer incorporates pH-responsive functional groups (carboxylic acid with pKa 4-6.5, imidazole with pKa 6-7, amine with pKa 8-10) that undergo protonation/deprotonation transitions at specific pH values, enabling automatic disassembly in acidic endosomal/lysosomal environments without complex external triggers

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The polymer acts as an intermediary carrier that protects drugs during circulation and facilitates their release in target cells through pH-triggered conformational changes, mediating between the drug and cellular environment

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If nanovesicles are used to cross physiological barriers, then drug delivery to target sites is improved, but manufacturing complexity increases

Engineering Contradiction:
Improvephysiological barrier crossingVSAvoidnanovesicle production
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The polymer is designed as an amphiphilic block copolymer with distinct hydrophobic and hydrophilic blocks that self-assemble into nanovesicles, dividing the complex delivery function into manageable structural segments

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The amphiphilic block copolymer automatically self-assembles into nanovesicles in aqueous environments without requiring complex external assembly processes, reducing manufacturing complexity while maintaining delivery efficacy

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polymersomes enhance intracellular drug delivery by selectively targeting disease cells, avoiding lysosomal degradation, and releasing the drug at the target site, thereby improving therapeutic efficacy and minimizing adverse effects.

Implementation Method 1

a pH sensitive biodegradable succinate polymer (b) comprising a pendant group with a pKa of from 4 to 7

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

Nanovesicles formed using PPITS, and derivatives thereof, are important because they enable drugs to cross physiological barriers to reach their target sites safely and sustainably

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Data Source

PatentUS12544334B2Metabolisable pH sensitive polymersomes
Publication Date: 2026.02.10 UCL BUSINESS LTD
  • US12544334B2 patent drawing
  • US12544334B2 patent drawing
  • US12544334B2 patent drawing

AI summary

The present application relates to pH-sensitive polymersomes. The polymersomes are capable of degradation at endosomes' mild acidic pH into resorbable materials, which also allows avoiding liposome premature degradation of the payload once internalised inside the cells. The polymersomes can thus be used in methods for the treatment or prevention of diseases.